Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Shah Keeren Rameshchandra — OKYO Pharma Ltd insider: 1 transactions · InsiderLens

Home / Insiders / Shah Keeren Rameshchandra

Shah Keeren Rameshchandra

CHIEF OPERATING & FIN. OFFICER at Tiziana Life Sciences Ltd · on record since May 22, 2026
Chief Financial Officer at OKYO Pharma Ltd · on record since May 22, 2026

Insider trading activity of Shah Keeren Rameshchandra

Transactions on record: 1; since Jun 10, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 10, 2026

Figures computed from official regulatory filings — methodology.

Companies where Shah Keeren Rameshchandra has traded

OKYO Pharma Ltd1 tx · $74K · Jun 10, 2026

Track record of Shah Keeren Rameshchandra

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Shah Keeren Rameshchandra

Co-insiders of Shah Keeren Rameshchandra

CERRONE GABRIELE MOKYO Pharma Ltd +1
BRANCACCIO JOHN POKYO Pharma Ltd
Dempsey Robert JohnOKYO Pharma Ltd
Denoyer BernardOKYO Pharma Ltd
JACOB GARY SOKYO Pharma Ltd
Mantelli FlavioOKYO Pharma Ltd
Shah KeerenOKYO Pharma Ltd

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Simon Willy JulesOKYO Pharma Ltd

Company	Filed	Type	Qty	Price	Value · USD	Src
OKYO Pharma Ltd	Jun 10, 2026	AwardD	40,000	1.85 USD	$74K	SEC